Clindamycin-hameln Solution for Injection 150mg/ml
Product details
Registration number: SIN14599P
Classification: Prescription Only
Active ingredients: Clindamycin Phosphate 178.23 mg/ml eqv Clindamycin
Strength: 150 mg/ml
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Registrant: ZYFAS PHARMA PTE LTD
ATC code: J01FF01
HSA approval date: 3 September 2014
Manufacturer(s): Siegfried Hameln GmbH
Manufacturing country/countries: GERMANY
What are the HSA registration number and classification for Clindamycin-hameln Solution for Injection 150mg/ml?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14599P
Classification: Prescription Only
What active ingredients and strength are recorded for Clindamycin-hameln Solution for Injection 150mg/ml?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Clindamycin Phosphate 178.23 mg/ml eqv Clindamycin
Strength: 150 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for Clindamycin-hameln Solution for Injection 150mg/ml?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SOLUTION
Route: INTRAVENOUS; INTRAMUSCULAR
Who is the recorded registrant for Clindamycin-hameln Solution for Injection 150mg/ml?
According to the HSA dataset updated 7 August 2026:
Registrant: ZYFAS PHARMA PTE LTD
Which manufacturers and countries are listed for Clindamycin-hameln Solution for Injection 150mg/ml?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Siegfried Hameln GmbH
Manufacturing country/countries: GERMANY
Where can I look up Clindamycin-hameln Solution for Injection 150mg/ml in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14599P or the exact product name Clindamycin-hameln Solution for Injection 150mg/ml. The general register link does not preselect this product.
What are the source dates for this Clindamycin-hameln Solution for Injection 150mg/ml record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this Clindamycin-hameln Solution for Injection 150mg/ml record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14599P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)